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.C.A.TrappenburgSummary
Introduction: Chronic disease management for patients with chronic obstructive
pulmonary disease (COPD) may improve quality, outcomes and access to care.
Objective: To investigate effectiveness of chronic disease management programmes on
the quality-of-life of people with COPD.
Methods: Medline and Embase (1995–2005) were searched for relevant articles, and
reference lists and abstracts were searched for controlled trials of chronic disease
management programmes for patients with COPD. Quality-of-life was assessed as an
outcome parameter. Two reviewers independently reviewed each paper for methodolo-
gical quality and extracted the data.
Results: We found 10 randomized-controlled trials comparing chronic disease manage-
ment with routine care. Patient populations, health-care professionals, intensity, and
content of the intervention were heterogeneous. Different instruments were used to
assess quality of life. Five out of 10 studies showed statistically significant positive
outcomes on one or more domains of the quality of life instruments. Three studies, partly
located in primary care, showed positive results.
Conclusions: All chronic disease management projects for people with COPD involving
primary care improved quality of life. In most of the studies, aspects of chronic disease
management were applied to a limited extent. Quality of randomized-controlled trials wasElsevier Ltd. All rights reserved.
538123; fax: +31 30 2505482.
@umcutrecht.nl (J.C.A. Trappenburg).
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A. Niesink et al.2234not optimal. More research is needed on chronic disease management programmes in
patients with COPD across primary and secondary care.
& 2007 Elsevier Ltd. All rights reserved.Contents
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Chronic obstructive pulmonary disease (COPD) is a major
cause of morbidity and mortality across the world, and its
prevalence continues to increase.1 COPD places a burden on
the health-care system and reduces health-related quality
of life (HRQOL).2,3 According to current guidelines, stable
COPD is managed using a combination of smoking cessation,
pharmacological therapy, education, pulmonary rehabilita-
tion, nutritional interventions, vaccinations, oxygen therapy
and surgery.1,4–7 This multi-component management of
COPD usually involves the use of many health-care provi-
ders. In spite of the given guidelines, it is still unclear what
is the most effective approach of delivering and co-
ordinating comprehensive and multidisciplinary care along
the disease continuum and across the different health-care
systems. In addition, it is conceptually unclear how such
programmes should be defined.8 A wide range of definitions
and concepts have been used for changes in healthcare
delivery (i.e. transmural care, shared care, multidisciplinary
care, integrated care and disease management). The most
frequently used innovative approach to avoid fragmentation
and discontinuity of health care is chronic disease manage-
ment. Chronic disease management programmes are inter-
ventions designed to manage or prevent a chronic condition
using a systematic approach to care, with the potential use
of multiple treatment modalities.9 Compared with tradi-
tional healthcare delivery, care delivered using chronic
disease management is organized, proactive and inte-
grated.10 Particularly, integration of health care is a
potential method of improving quality, access, user satisfac-
tion and efficiency of care for patients with chronic
illness.8,9,11 The World Health Organization defines inte-
grated healthcare services as a concept of bringing together
inputs, delivery, management and organization of services
related to diagnosis, treatment, care, rehabilitation and
health promotion.11In assessing the effectiveness of treatment for COPD, the
appropriate selection of outcome measurement is critical.
Objective pulmonary function parameters, such as forced
expiratory volume in 1 s (FEV1), provide the clinician with an
appropriate means of diagnosis, stage severity and prognosis
of COPD. However, reduction in FEV1 is only weakly
associated with the patient’s perception of symptoms and
health-HRQOL.12 Furthermore, HRQOL is dynamic within the
individual, varying with changes in both disease intensity
and expectations of health.13 Exacerbation of COPD is a
particularly important, negative influence on HRQOL.3
Consequently, improving quality of life is considered to be
a major goal in widely recognized guidelines for the
management of COPD.1,4–7 The objective of this systematic
review is to summarize the effects of integrating care within
chronic disease management programmes on quality of life
in people with COPD.Methods
For this systematic review, Medline and Embase were
searched between 1995 and 2006; using the following key
words: ‘COPD’ or ‘chronic obstructive pulmonary disease’ or
‘pulmonary emphysema’ or ‘chronic bronchitis’; and ‘qual-
ity of life’ or ‘health status’ or ‘health status indicators’.
We selected only randomized-controlled studies compar-
ing quality of life outcomes in outpatient chronic disease
management programmes and routine care. We particularly
focused on the level of integration or interconnection of
COPD-care disciplines or healthcare systems. We excluded
studies aimed exclusively at evaluations of methods of
case finding, prevention strategies, provider education or
provider feedback. Programmes were considered to be
integrated care if at least one of the following components
was present: (1) multidisciplinary care team, (2) clinical
pathway, (3) clinical follow-up, (4) case management, or
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Table 1 Inclusion criteria and study flow from identification to final inclusion.
Inclusion criteria Number of studies
excluded
Cumulative number
of studies
Identification of studies 2098
Title and abstract screening 2000 98
Methodological criteria Randomized-controlled trial 41 57
Control group with care-as-usual 13 44
Study population criteria Clinical diagnosed COPD patients
stable at inclusion
3 41
Intervention criteria Outpatient integrated care
programme
9 32
Duration of at least 8 weeks 4 28
Outcome measurements General or disease-specific
instrument measuring quality of
life
18 10
COPD, chronic obstructive pulmonary disease.
Outpatient programme, including at least one of the following components: (1) multidisciplinary care team, (2) clinical pathway,
(3) clinical follow-up, (4) case management, and (5) self-management or patient education.
The effects of chronic disease management on quality of life in people with COPD 2235(5) self-management or patient education.8 Additional inclu-
sion criteria used to select studies are shown in Table 1.
Studies published before 1995 were not considered for
inclusion, as new guidelines for management of COPD were
published in 1995.1,4–7 The reference lists of the selected
studies and relevant reviews were inspected for additional
papers. Two reviewers (AN and GdW) independently evaluated
the full text of all retrieved papers, made a decision on
inclusion or exclusion, and discussed the decisions. Any
disagreement was resolved by consensus, with close attention
to inclusion and exclusion criteria. Data were collected using a
standardized abstraction form. To assess methodological
quality, criteria developed by the Cochrane Back Review
Group were used.14 The following 11 criteria were assessed:
adequate randomization procedure, concealment of treat-
ment allocation, similarity of baseline characteristics, blind-
ing of patients, blinding of care provider, outcome assessor
blinded to the intervention, co-interventions avoided or
equal, compliance, withdrawal or drop-out rate, similarity
of timing outcome assessment, and intention-to-treat ana-
lyses. A total score was computed by counting the number of
criteria that were met. High quality was defined as fulfilling
six or more of the 11 validity criteria.
To determine the effects of chronic disease management
programmes on the quality of life of people with COPD,
included studies were analysed for statistically significant
differences (Pp0.05), as well as clinically significant
differences in quality of life. Missing data from the primary
study reports were requested from the investigators.
Results
Study selection
An overview of the study selection process is shown in Table
1. The initial search strategy identified 2098 references.
After screening titles and abstracts, 98 potentially relevantarticles were identified. Ten randomized-controlled trials
met all our inclusion criteria.15–24Content of the interventions
Characteristics of the included studies are described in
Table 2. All programmes contained education, and nine
studies included exercise training; however, the study by
Rea et al.16 carried out a care plan, consisting of a timetable
for regular maintenance checks and setting achievable goals
for lifestyle changes. Monninkhof et al.15 and Bourbeau
et al.17 used an action plan to improve self-management in
case of exacerbations. The interventions studied also
included scheduled appointments with a doctor to monitor
patients,20,24 psychosocial support,21 relaxation techni-
ques21,23 smoking cessation,22 breathing retrain-
ing,18–20,23,24 recreational activities for patients23 and
occupational therapy.22
Duration of the interventions varied from 2 to 18 months.
The frequency of contact with care providers differed from
4 h daily to 2 h a week. Most interventions took place in
secondary care. Three interventions were located in primary
care, and included general practitioners, nurses, and
physiotherapists.16,23,24 In secondary care, besides nurses
and physiotherapists, clinicians, occupational therapists,
psychologists, dieticians and social workers were also
involved. The number of disciplines included in the studies
reviewed ranged from two to seven.Patient characteristics
Patient characteristics of the populations studied are shown
in Table 3. Because of differences in inclusion criteria, the
proportion of men and women, and the degree of airflow
limitation as measured by FEV1 as a percentage of the
predicted value, differed among the studies. Patients’ mean
ARTICLE IN PRESS
Table 2 Characteristics of studies included in the review.
Reference Follow-
up
(months)
Quality
of study
Number of
providers
primary care/
secondary
care
Content intervention group
I II III IV V VI VII VIII IX X
Rea et al.,16 New Zealand 12 6 2/2 1 – – – – – – – – 1
Monninkhof et al.,15 The
Netherlands
12 8 0/3 1 – 2 – – – – – – 1
Bourbeau et al.,17 Canada 12 8 0/3 1 – 3 – – – – – – 1
Gu¨ell et al.,18 Spain 12 7 0/2 1 – 3 3 – – – – – –
Ringbeak et al.,19 Denmark 2 3 0/5 3 – 3 3 – – – – – –
Engstro¨m et al.,20 Sweden 12 6/7 0/5 1 1 2 2 – – – – – –
Emery et al., USA21 2.5 6 0/2 a:3 – a:3 – a:3 – – – a:2/ –
b:3 b:
–
b:3 b:2
Bendstrup et al.,22
Denmark
3 4 0/7 2 – 3 – – – 1 1 – –
Cambach et al.,23 The
Netherlands
3 4 3/1 3 – 3 3 2 2 – – – –
Wijkstra et al.,24 The
Netherlands
18 5 3/1 c:1 C:1 c:3 c:3 – – – – – –
d:1 d:1 d:1 d:1
(I) Education, (II) scheduled visit physician, (III) exercise, (IV) breathing retraining, (V) relaxation techniques, (VI) recreation, (VII)
occupational therapy, (VIII) smoking cessation support, (IX) psychological support, (X) action plan. –: absent; 1: less than once a week;
2: once a week; 3: more than once a week. a: intervention with exercise; b: intervention without exercise; c: intervention with weekly
session physiotherapist; d: intervention of a monthly session with a physiotherapist.
A. Niesink et al.2236age was approximately equal among the studies, varying
from 62 to 69 years. The number of participants included in
the studies was relatively small. Seven out of 10 studies
included fewer than 30 patients in the intervention or
control group.
Methodological quality
In general, the methodological quality of the studies
included in this review was moderate (Table 3). Six studies
achieved six or more positive scores on the validity criteria,
the determined threshold for high quality. All included
studies were randomized-controlled trials. None of the
studies were double-blinded, because blinding of patients
and care providers is not possible in this type of study.
Synthesis of the findings
Quality of life was determined at baseline and after the
intervention. In Table 3, outcomes on quality of life are
summarized. Five studies reported statistically significant
differences between the intervention group and the control
group in one or more domains of the quality of life
instrument.16,18,21,23,24 Four of these studies used the
Chronic Respiratory Questionnaire (CRQ) to determine
quality of life.16,18,23,24 Gu¨ell et al.18 and Cambach et al.23
found statistically significant improvement in quality of life
between the intervention group and the control group for all
four domains of the CRQ. Rea et al.16 reported statistically
significant changes in the ‘fatigue’ and ‘mastery’ domain,and Wijkstra et al.24 in the ‘mastery’ domain of the CRQ. In
the study by Emery et al.,21 a statistically significant
improvement in quality of life was found between patients
in the intervention group and the control group, using the
Sickness Impact Profile.
Table 3 also shows which studies reported clinically
relevant differences in quality of life between baseline
and after the intervention among the intervention group and
the control group. Seven studies found differences above
the minimal clinically important difference threshold in the
intervention group16–20,23,24; in four studies, clinically
relevant improvements in the control group were
seen.16,17,19,20 Gu¨ell et al.,18 Cambach et al.23 and Wijkstra
et al.24 reported differences in the CRQ above the minimal
clinically significant difference threshold in the intervention
group, and no clinically relevant improvements in the
control group.18,23,24 No clinically significant deteriorations
were found in any of the studies.Discussion
In this review, outcome on quality of life of 10 chronic
disease management trials concerning integrated care in
patients with stable COPD were reviewed. Five studies
showed statistically significant positive effects on one or
more subscales of the quality of life instruments in the
intervention group, compared with the control group. This
included all trials partly located in primary care. These
three trials also showed clinically significant improvements
in quality of life in the intervention group. In addition to
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Table 3 Characteristics of study participants and outcomes on quality of life.
N Sex (% male)
intervention-
control
Mean age
intervention/
control
FEV1 (%pred)
intervention/
control
Instruments
used to assess
quality of life
Statistical
outcomes on
quality of life
between
groups
Clinical
relevant
outcomes
on quality of
life I
Clinical
relevant
outcomes
on quality of
life C
Rea et al.16 117 42 (total) 68 (total) 52/50 CRQ, SF36 * (CRQ) ¼ (SF-36) – (CRQ)
+ (SF-36) – (CRQ) + (SF-36)
Monninkhof et al.15 248 67/69 65/65 56/58 SGRQ ¼ – –
Bourbeau et al.17 191 52/59 69/70 n.a. CRQ ¼ + +
Gu¨ell et al.18 47 100/100 63/65 32/41 CRQ * + –
Ringbeak et al.19 45 4/29 62/65 50/44 SGRQ ¼ + +
Engstro¨m et al.20 50 54/50 66/77 31/34 SGRQ, SIP ¼ (SGRQ) + (SGRQ) + (SGRQ)
¼ (SIP) n.a. (SIP) n.a. (SIP)
Emery et al.21 79 a:50/48 65/67 43/39 SIP a:* n.a. n.a.
b:42 67 43 b:*
Bendstrup et al.22 32 56/56 64/65 1.02L/min CRQ ¼ – –
1.04L/min
Cambach et al.23 23 47/75 62/62 59/60 CRQ * + –
Wijkstra et al.24 36 c:73/92 62/62 43/43 CRQ c: ¼ c:– –
d:83 64 45 d:* d:+
a: Intervention with exercise training; b: intervention without exercise training; c: intervention with weekly session with physiotherapist; d: intervention with monthly session with
physiotherapist. CRQ, Chronic Respiratory Questionnaire; SGRQ, St. George Respiratory Questionnaire; SF-36, Short Form-36; SIP, Sickness Impact Profile. *, Statistically significant
improvement one or more quality of life domains; ¼ , no statistically significant changes on any quality of life domains; +, clinically relevant improvement one or more quality of life
domains; –, no clinically relevant improvement one or more quality of life domains (minimal clinical relevant difference CRQ: 0.5 points on seven-point scale; SGRQ, four points; SF-36,
3–5 points; SIP, not determined); n.a., not applicable.
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A. Niesink et al.2238primary care, secondary-care professionals, including gen-
eral physicians, physiotherapists, nurses, and pulmonary
specialists, were involved in these projects. Most of the
trials included in this review studied the effects of
pulmonary rehabilitation, including exercise.15,17–24 This
confirms the findings of Lacasse et al.,25 who recently
carried out a meta-analysis of 23 randomized-controlled
trials of inpatient, outpatient, and home-based pulmonary
rehabilitation programmes for people with COPD. Pulmonary
rehabilitation showed statistically significant and clinically
relevant improvements in HRQOL, irrespective of whether or
not they were part of integrated care. Two studies selected
in our review assessed the effects of self-management.15,17
Only one study reported improvements in quality of life
domains. This supports the inconclusive findings of a
systematic review studying the effects of self-management
programmes on quality of life outcomes.26 In our study,
positive effects relating to quality of life were particularly
seen when the disease-specific instrument CRQ was used to
determine quality of life. General quality of life instruments
are apparently less sensitive to detecting differences in
quality of life in interventions for people with COPD. For
other chronic diseases, such as diabetes, heart failure and
depression, studies on chronic disease management, includ-
ing primary care, showed inconclusive results on quality of
life. Some studies found statistically significant improve-
ments in quality of life between the intervention group and
the control group,27,28 whereas other studies found no
differences in quality of life.29,30
The results of this review need to be interpreted with
caution. First, large variations were found in study popula-
tion, design, duration, content, outcomes and intensity of
the interventions. All included studies were randomized-
controlled trials, with substantial variation in methodologi-
cal quality. The trials were not blinded for obvious practical
reasons, and quality of life outcomes were not always shown
properly, as quality of life was not the primary outcome in
all the studies. Second, selection bias may have occurred
because we relied on English papers. Third, the current
selection of studies did not focus on the all the effects of
chronic disease management or integrated care pro-
grammes. In most of these studies, only one or more
components were applied (i.e. multiple treatment modal-
ities or self-management interventions). In addition, in most
studies, little information was provided on the specific
characteristics of collaboration between different disci-
plines. The current model of chronic disease management
and integrated care, embraced by the World Health
Organization, have their origins in the chronic care model
developed by Wagner.31 He identified six essential elements
for quality in chronic care: community resources and
policies, health-care organization, self-management sup-
port for patients, delivery-system design, decision support,
and clinical information systems. The studies in this review
did not include all elements of this chronic care model. In
the chronic care model, successful chronic disease manage-
ment requires a co-ordinated multidisciplinary care team.31
Quality of communication and collaboration between care
providers, and communication with patients, seems to be
highly important in improving care for chronically ill
patients. Lack of information, however, detracts from the
elements of co-operation that are essential for successfuloutcome. Our findings are consistent with a recent
systematic review,32 showing that data on efficacy of
elements of the chronic care model are limited in patients
with COPD. However, the authors applied different inclusion
criteria in their analysis, and therefore were able to pool
data; they also could not detect significant changes in
quality of life.
To date, only Casas et al.33 have studied all the effects of
shared and integrated COPD care between primary-care teams
and hospital teams, aiming at generating synergies among
different levels of the health-care system and avoiding dupli-
cation. Although no improvements in HRQOL were observed,
the proposed model of integration between disciplines and
health-care systems offers great potential in reducing hospital
rates.33 As this trial only focused on patients with exacerbated
COPD, it was excluded from the current review.
Conclusion
The number of studies of chronic disease management and
integration of care for patients with stable COPD that have
assessed outcome on quality of life is limited. It is
inconclusive whether these programmes, with different
levels of integration, improve quality of life. Involvement
of primary care in managing COPD seems to have a positive
effect on the quality of life of these patients. However, the
level of effective integrated care needs to be determined.
Implementation in daily practice also needs to be assessed
for feasibility and sustainability (including economic).
Future research on the effectiveness of chronic disease
management programmes should focus on structural im-
plementation strategies of guidelines for managing COPD in
primary and secondary care. In addition, more scientific
evidence is needed to define the optimal approach of
delivering and co-ordinating comprehensive COPD care
across different health-care systems.Practice points
 Data on efficacy of chronic disease management and
elements of the chronic care model in patients with
COPD are limited.
 It is inconclusive whether chronic disease manage-
ment programmes in people with stable COPD can
improve HRQOL.
 Involvement of primary care seems to have a
positive effect on HRQOL in people with stable
COPD.Research directions
 The benefits of structural implementation of multi-
disciplinary guidelines involving both primary and
secondary care needs to be more clearly defined.
 The most effective method of integrating different
disciplines and healthcare systems and avoiding
fragmentation and discontinuation of COPD care
remains to be determined.
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